PDF-ikonPrintikon

Litteratur

Yderligere læsning for interesserede

     (1)  Aaby P, Roth A, Ravn H, Napirna BN, Rodrigues A, Lisse IM et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: Beneficial non-specific effects in the neonatal period? The Journal of Infectious Disease. In press 2011.

    (2)   Benn CS, Fisker AB, Napirna BM, Roth A, Diness BR, Lausch KR et al. Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. BMJ 2010;340:c1101.

    (3)   Roth AE, Benn CS, Ravn H, Rodrigues A, Lisse IM, Yazdanbakhsh M et al. Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. BMJ 2010;340:c671.

    (4)   Roth A, Jensen H, Garly ML, Djana Q, Martins CL, Sodemann M et al. Low birth weight infants and Calmette-Guerin bacillus vaccination at birth: community study from Guinea-Bissau. Pediatr Infect Dis J 2004 June;23(6):544-50.

    (5)  Garly ML, Martins CL, Balé C, Baldé MA, Hedegaard KL, Gustafson P et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa: A non-specific beneficial effect of BCG? Vaccine 2003;21:2782-90.

    (6)   Roth A, Gustafson P, Nhaga A, Djana Q, Poulsen A, Garly ML et al. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol 2005 June;34(3):540-7.

    (7)   Roth A, Sodemann M, Jensen H, Poulsen A, Gustafson P, Weise C et al. Tuberculin reaction, BCG scar, and lower female mortality. Epidemiology 2006 September;17(5):562-8.

     (8)  Aaby P, Shaheen SO, Heyes CB, Goudiaby A, Hall AJ, Shiell AW et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000 May;30(5):644-50.

    (9)   Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999 August 15;163(4):2249-55.

  (10)   Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children [see comments]. Lancet 1999 January 16;353(9148):196-200.

  (11)   Eifan AO, Akkoc T, Ozdemir C, Bahceciler NN, Barlan IB. No association between tuberculin skin test and atopy in a bacillus Calmette-Guerin vaccinated birth cohort. Pediatr Allergy Immunol 2009 September;20(6):545-50.

  (12)   Dilli D, Bostanci I, Dallar Y. Do different vaccination regimens for BCG and hepatitis B affect the development of allergic disorders in early childhood? J Asthma 2008 March;45(2):155-9.

  (14)   Soysal A, Bahceciler N, Barlan I, Bakir M. Lack of an inverse association between tuberculosis infection and atopy: by T-cell-based immune assay (RD1-ELISpot). Pediatr Allergy Immunol 2008 December;19(8):709-15.

  (15)   Li J, Zhou Z, An J, Zhang C, Sun B, Zhong N. Absence of relationships between tuberculin responses and development of adult asthma with rhinitis and atopy. Chest 2008 January;133(1):100-6.

  (16)   Ahmadiafshar A, Parchegani MR, Moosavinasab N, Koosha A. A Study of Relation between BCG Scar and Atopy in Schoolchildren of Zanjan City. Iran J Allergy Asthma Immunol 2005 December;4(4):185-8.

  (17)   Omar MT, Ahmed SH, Sarkis NN. A study of the association between delayed type hypersensitivity reaction to mycobacterium tuberculosis and atopy in asthmatic children. J Egypt Public Health Assoc 2005;80(3-4):463-74.

  (18)   Obihara CC, Beyers N, Gie RP, Potter PC, Marais BJ, Lombard CJ et al. Inverse association between Mycobacterium tuberculosis infection and atopic rhinitis in children. Allergy 2005 September;60(9):1121-5.

  (19)   Annus T, Montgomery SM, Riikjarv MA, Bjorksten B. Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination. Allergy 2004 October;59(10):1068-73.

Sidst redigeret 4. september 2012